Prevention of Sympathetic and Cardiac Dysfunction after Myocardial Infarction in Transgenic Rats Deficient in Brain Angiotensinogen

Circulation Research

Volumn 94, Issue 6, 2004, Pages 843-849

  Wang, Hao ^a   Huang, Bing S ^a   Ganten, Detlev ^b   Leenen, Frans H H ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Angiotensin; Arterial baroreflex; Brain; Cardiac remodeling; Left ventricular dysfunction

Indexed keywords

ANGIOTENSINOGEN; COMPLEMENTARY RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CIRCULATION; CORONARY ARTERY LIGATION; EVIDENCE BASED MEDICINE; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART MUSCLE FIBROSIS; HEART RATE; HEART RIGHT VENTRICLE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE REMODELING; MALE; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROPHYLAXIS; RAT; RAT STRAIN; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; TRANSGENIC MOUSE;

ANGIOTENSIN II; ANGIOTENSINOGEN; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BAROREFLEX; BRAIN; DNA, ANTISENSE; GENES, SYNTHETIC; GLIAL FIBRILLARY ACIDIC PROTEIN; HEART RATE; HYPOTHALAMUS; INJECTIONS, INTRAVENTRICULAR; MALE; MYOCARDIAL INFARCTION; ORGAN SIZE; PROMOTER REGIONS (GENETICS); RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; REFLEX, ABNORMAL; RENIN-ANGIOTENSIN SYSTEM; STRESS, PSYCHOLOGICAL; STROKE VOLUME; SYMPATHETIC NERVOUS SYSTEM; TRANSGENES; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 1842455238     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000120864.21172.5A     Document Type: Article

References (39)

1. Pfeffer JM, Pfeffer MA, Fletcher PJ, Braunwald E. Progressive ventricular remodeling in rats with myocardial infarction. Am J Physiol. 1991;260:H1406-H1414.
2. Capasso JM, Li P, Zhang X, Anversa P. Heterogeneity of ventricular remodeling after acute myocardial infarction in rats. Am J Physiol. 1992;262: H486-H495.
3. Rundqvist B, Elam M, Bergmann-Sverrisdottir Y, Eisenhofer G, Friberg P. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation. 1997;95:169-175.
4. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol. 1992;20:248-254.
5. Heidenreich PA, Lee TT, Massie BM. Effect of β-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol. 1997;30:27-34.
6. Leenen FHH, Huang BS, Yu H, Yuan B. Brain "ouabain" mediates sympathetic hyperactivity in congestive heart failure. Circ Res. 1995;77:993-1000.
7. Zhang W, Huang BS, Leenen FHH. Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction. Am J Physiol. 1999;276:H1608-H1615.
8. DiBona GF, Jones SY, Brooks VL. ANG II receptor blockade and arterial baroreflex regulation of renal nerve activity in cardiac failure. Am J Physiol. 1995;269:R1189-R1196.
9. Leenen FHH, Yuan B, Huang BS. Brain "ouabain" and angiotensin II contribute to cardiac dysfunction after myocardial infarction. Am J Physiol. 1999;277:H1786-H1792.
10. Leenen FHH, Skarda V, Yuan B, White R. Changes in cardiac angiotensin II post myocardial infarction in rats: effects of nephrectomy and ACE inhibitors. Am J Physiol. 1999;45:H317-H325.
11. McKinley MJ, McAllen RM, Mendelsohn FAO, Allen AM, Chai SY, Oldfield BJ. Circumventricular organs: Neuroendocrine interfaces between the brain and the hemal milieu. Front Neuroendocrinol. 1990;11:91-127.
12. 2 receptor in the brain in regulation of blood pressure and water intake. Am J Physiol. 2003;284:H116-H121.
13. 1-receptor-independent functions of losartan. Circ Res. 2002;90:754-756.
14. Schinke M, Baltatu O, Bohm M, Peters J, Rascher W, Bricca G, Lippoldt A, Ganten D, Bader M. Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen. Proc Natl Acad Sci U S A. 1999;96:3975-3980.
15. + and ouabain are attenuated in transgenic rats deficient in brain angiotensinogen. Hypertension. 2001;37:683-686.
16. Baltatu O, Silva JA Jr, Ganten D, Bader M. The brain renin-angiotensin system modulates angiotensin II-induced hypertension and cardiac hypertrophy. Hypertension. 2000;35:409-412.
17. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, Braunwald E. Myocardial infarct size and ventricular function in rats. Circ Res. 1979;44:503-512.
18. Huang BS, Leenen FHH. Brain "ouabain" mediates the sympatho-excitatory and hypertensive effects of high sodium intake in Dahl salt-sensitive rats. Circ Res. 1994;74:586-595.
19. Huang BS, Yuan B, Leenen FHH. Blockade of brain "ouabain" prevents the impairment of baroreflexes in rats post myocardial infarction. Circulation. 1997;96:1654-1659.
20. Fletcher PJ, Pfeffer MJ, Pfeffer MA, Braunwald E. Left ventricular diastolic pressure-volume relations in rats with healed myocardial infarction: effects on systolic function. Circ Res. 1981;49:618-626.
21. Chien YW, Barbee RW, MacPhee AA, Frohlich ED, Trippodo NC. Increased ANF secretion after volume expansion is preserved in rats with heart failure. Am J Physiol. 1988;254:R185-R191.
22. + in Dahl salt-sensitive vs resistant rats. Am J Physiol. 2001;281:H1881-H1889.
23. Lal A, Veinot JP, Leenen FHH. Prevention of high salt diet-induced cardiac hypertrophy and fibrosis by spironolactone. Am J Hypertens. 2003;16:319-323.
24. Head GA, McCarty R. Vagal and sympathetic components of the heart rate range and gain of the baroreceptor-heart rate reflex in conscious rats. J Auton Nerv Syst. 1987;21:203-213.
25. Phillips MI. Functions of angiotensin in the central nervous system. Annu Rev Physiol. 1987;49:413-435.
26. Milsted A, Barna BP, Ransohoff RM, Brosnihan KB, Ferrario CM. Astrocyte cultures derived from human brain tissue express angiotensinogen mRNA. Proc Natl Acad Sci USA. 1990;87:5720-5723.
27. Monti J, Schinke M, Bohm M, Ganten D, Bader M, Bricca G. Glial angiotensinogen regulates brain angiotensin II receptors in transgenic rats TGR(ASrAOGEN). Am J Physiol. 2001;280:R233-R240.
28. Pfeffer JM, Pfeffer MA, Braunwald E. Hemodynamic benefits and prolonged survival with long-term captopril therapy in rats with myocardial infarction and heart failure. Circulation. 1987;75:1149-1155.
29. Kawano Y, Yoshida K, Matsuoka H, Omae T. Chronic effects of central and systemic administration of losartan on blood pressure and baroreceptor reflex in spontaneously hypertensive rats. Am J Hypertens. 1994;7:536-542.
30. Jain M, Liao R, Ngoy S, Whittaker P, Apstein CS, Eberli FR. Angiotensin II receptor blockade attenuates the deleterious effects of exercise training on post-MI ventricular remodeling in rats. Cardiovasc Res. 2000;46:66-72.
31. 1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin. Cardiovasc Res. 1998;39:401-412.
32. Hao J, Wang B, Jones SC, Jassal DS, Dixon IM. Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro. Am J Physiol. 2000;279:H3020-H3030.
33. + exchanger and LV dysfunction after myocardial infarction in rats. Am J Physiol. 1999;277:H610-H616.
34. 1-receptor blockers. J Cardiovasc Pharmacol. 2003;41:593-599.
35. Muratani H, Teruya H, Sesoko S, Takishita S, Fukiyama K. Brain angiotensin and circulatory control. Clin Exp Pharmacol Physiol. 1996;23:458-464.
36. Parmley WW. Neuroendocrine changes in heart failure and their clinical relevance. Clin Cardiol. 1995;18:440-445.
37. Francis J, Weiss RM, Wei S-G, Johnson AK, Felder RB. Progression of heart failure after myocardial infarction in the rat. Am J Physiol. 2001;281:R1734-R1745.
38. Wada K, Tahara A, Arai Y, Aoki M, Tomura Y, Tsukada J, Yatsu T. Effect of vasopressin receptor antagonist conivaptan in rats with heart failure following myocardial infarction. Eur J Pharmacol. 2002;450:169-177.
39. Francis J, Weiss RM, Johnson AL, Felder RB. Central mineralocorticoid receptor blockade decreases plasma TNF-α after coronary artery ligation in rats. Am J Physiol. 2003;284:R328-R335.